Inflammation-Driven Genomic Instability: A Pathway to Cancer Development and Therapy Resistance
Year: 2025
Type: review
Abstract: Chronic inflammation, while originally a protective physiological response, is increasingly recognized as a key contributor to carcinogenesis. Prolonged inflammatory signaling leads to the sustained production of reactive oxygen and nitrogen species (ROS/RNS), resulting in direct and indirect DNA damage, including base modifications, strand breaks, and DNA cross-linking. Simultaneously, pro-inflammatory mediators such as NF-κB, IL-6, and TNF-α can interfere with DNA repair mechanisms, altering the efficiency of key pathways such as base excision and mismatch repair. Immune cells infiltrating chronically inflamed tissues, including macrophages and neutrophils, further exacerbate genomic instability through ROS/RNS release and cytokine production, creating a tumor-promoting microenvironment. Additionally, chronic inflammation has been implicated in the development of resistance to chemotherapy and radiotherapy by modulating DNA damage response pathways. Understanding the interplay between inflammation, genomic instability, and therapy resistance provides a framework for novel treatment strategies. Targeting chronic inflammation with non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or biological agents such as monoclonal antibodies offers promising avenues for cancer prevention and treatment. Targeting inflammation with NSAIDs, corticosteroids, and monoclonal antibodies shows promise in cancer prevention and therapy, particularly in lung and pancreatic cancer. These agents act by blocking key inflammatory pathways like COX-2, NF-κB, and cytokine signaling. However, potential adverse effects require further clinical evaluation.
Source: Pharmaceuticals
DOI: 10.3390/ph18091406
Authors: Nina Rembiałkowska, Zofia Kocik, Amelia Kłosińska, Maja Kübler, Agata Pałkiewicz, Weronika Rozmus, Mikołaj Sędzik, Helena Wojciechowska, Agnieszka Gajewska-Naryniecka
Institution: Wroclaw Medical University
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: chronic inflammation, genomic instability, carcinogenesis, treatment resistance, reactive oxygen species, reactive nitrogen species, DNA damage, DNA repair, NF-κB, interleukin-6, TNF-α, base excision repair, DNA mismatch repair, tumor microenvironment, macrophages, neutrophils, DNA damage response, chemoresistance, radiotherapy resistance, nonsteroidal anti-inflammatory drugs, corticosteroids, monoclonal antibodies, cyclooxygenase-2, lung cancer, pancreatic cancer, cancer prevention
Open Access status: gold
Estimated APC paid: $3,499
Award: G3845016854
OpenAlex ID: W4414326904
